GlassScriptPhysician profile
Jillian Sinopoli
NPI 1801236153
$3,137.40
in general payments reported to CMS, 2019-2025
15 companies · $457 in 2025
The $457 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $360 · 2022: $1,017 · 2023: $457 · 2024: $847 · 2025: $457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,761.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,761.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,040.45 | 2022-2025 | Da Vinci Surgical System |
| Ethicon US, LLC | $798.92 | 2021-2025 | Surgicel Nu-Knit, Ethicon, Echelon; Endopath |
| Astrazeneca Pharmaceuticals LP | $406.56 | 2023-2024 | Tagrisso |
| Davol INC. | $288.89 | 2022-2024 | Progel Applicator Spray Tips |
| Atricure, INC. | $212.05 | 2021-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Zimmer Biomet Holdings, INC. | $127.27 | 2024 | Advantagerib |
| Medtronic, INC. | $97.91 | 2023 | Signia |
| Ucb, INC. | $36.68 | 2024 | Cimzia |
| Becton, Dickinson and Company | $26.51 | 2025 | Pleurx |
| Lilly USA, LLC | $22.41 | 2023 | Taltz |
| Ethicon INC. | $22.23 | 2024 | Monarch Platform |
| Medical Device Business Services, INC. | $16.95 | 2021 | |
| Ferring Pharmaceuticals INC. | $16.80 | 2025 | Rebyota |
| Bard Peripheral Vascular, INC. | $15.60 | 2021 | |
| Kls-Martin L.P. | $8.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jillian Sinopoli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.